The University of Virginia has installed the Xstrahl SARRP research platform, an advanced, flexible system for radiation biology and pre-clinical research.
The SARRP platform enables image-guided micro-irradiation (IGMI) techniques to be performed in in vivo models and allows researchers to replicate the radiotherapy process of imaging, targeting localisation and radiotherapy treatment delivery to patients.
The technological improvements provided by the SARRP platform is hoped to enhance the radiation-based research capabilities at the University of Virginia.
It will also enable a wide range of basic and translational oncology research investigations as well as research into immunology and cardiovascular diseases.
Furthermore, investigations on re-evaluating the short- and long-term effects of current radiation therapies can be performed and their efficacy validated.
'The powerful imaging and flexibility of the SARRP platform with its strong scientific validation made it an obvious choice to support the many diverse radiation-based research activities carried out at the Medical School,' said Dr Ke Sheng, associate professor, Department of Radiation Oncology, University of Virginia.
'In addition, its compact footprint meant we were able to fit it into a shielded room without major renovation,' added Sheng.
